Animal Healthcare Division
Oclacitinib
Oclacitinib is a JAK inhibitor used for the treatment of allergic dermatitis and atopic dermatitis in dogs.
AvailableAnti-inflammatoryCAS 1208313-26-9
WHO-GMP Network
JAK inhibitor
Available
Oclacitinib is a JAK inhibitor used for the treatment of allergic dermatitis and atopic dermatitis in dogs.
Technical Overview
Oclacitinib – CAS 1208313-26-9
CAS Number
1208313-26-9
Category
Anti-inflammatory
Therapeutic Class
JAK inhibitor
Description
Oclacitinib is a JAK inhibitor used for the treatment of allergic dermatitis and atopic dermatitis in dogs.
Applications
- Allergic dermatitis
- Atopic dermatitis
- Pruritus control
Product Inquiry
Disclaimer
Products offered are intended strictly for veterinary use, R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.